FNY Investment Advisers »

Xenon Pharmaceuticals shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $244k 4.2k 58.10

More positions owned by FNY Investment Advisers

Global X Fds global x copper (COPX)
Codere Online Luxembourg Ord (CDRO)
Sealed Air
Clearw.a.hld. (CWAN)
Fonar Corporation (FONR)
Wix (WIX)
Deere & Company (DE)
Amicus Therapeutics (FOLD)
Futurecrest Acquisition Corp (FCRS.U)
Seabridge Gold (SA)
Cme (CME)
Norfolk Southern (NSC)
Willow Lane Acquisition Corp (WLAC)
Terns Pharmaceuticals (TERN)
Astrazeneca Plc Ord (AZN)

View all positions for FNY Investment Advisers

Top funds holding Xenon Pharmaceuticals

FMR
BlackRock
venBio Select Advisor
Wellington Management Company
Driehaus Capital Management
Henderson Group
Citadel Advisors
Capital Research and Management Company - Division 3
Polar Capital Holdings
Deerfield Management Company
Holocene Advisors
State Street Corporation
Alliancebernstein
Westfield Capital Management Company
Braidwell

View all funds holding Xenon Pharmaceuticals